M Cruciani, C Mengoli, M Malena, O Bosco… - … transplantation, 2006 - Wiley Online Library
… meta-analysis to determine whether antifungal prophylaxis decreases infectious morbidity and mortality in livertransplant … of antifungal prophylaxis in livertransplant patients. Concerns …
… We performed additional meta-regression to determine whether these favorable outcomes were due to the effects of vitamin E or attributed to the co-interventions. According to our …
F Fabrizi, V Dixit, P Martin, P Messa - Digestive diseases and sciences, 2011 - Springer
… in long-term survivors after livertransplantation. Several studies to clarify the risk factors for incidence of chronic kidney disease among livertransplant recipients, including preoperative …
P Wang, P Xun, K He, W Cai - Digestive and Liver Disease, 2016 - Elsevier
… livertransplantation outcomes, we systematically reviewed the literature and performed a meta-… , both for the PE itself and for livertransplantation. In addition, the information contributes …
GC Sotiropoulos, H Lang, S Nadalin… - Journal of the American …, 2007 - Elsevier
… One hundred patients with hepatocellular carcinoma underwent livertransplantation at our center during an 8-year period. Fifty-five patients received deceased donor livers and the …
Background & Aims Down-staging is commonly used to select patients with hepatocellular carcinoma (HCC) beyond Milan criteria (MC) for livertransplantation (LT), but outcomes are …
… of active MTB infection following livertransplantation or (2) cases of livertransplant candidates or recipients who received LTBI treatment prior to transplantation. We excluded cases of …
SA Acuna, W Zhang, PD Yoon, T Ivanics, MP Zhu… - …, 2022 - journals.lww.com
… Living donor livertransplantation (LDLT) is effective in expanding the donor pool and … adult-to-child livertransplantation as a response to shortages of livers for pediatric patients. Soon …
R Loomba, AK Rowley, R Wesley, KG Smith… - Clinical …, 2008 - Elsevier
… The results of this meta-analysis indicated that the HBIG and LAM combination therapy is markedly better than HBIG alone in the post–livertransplantation setting for the prevention of …